The Prevalence of Osteoporosis in Hemodialysis Patients

This study has been completed.
Sponsor:
Information provided by:
Papageorgiou General Hospital
ClinicalTrials.gov Identifier:
NCT00308828
First received: March 29, 2006
Last updated: June 5, 2008
Last verified: June 2008
  Purpose

The purpose of this study is to determine the prevalence and severity of osteoporosis in hemodialysis patients and to evaluate potential correlations with renal bone disease indices


Condition Phase
Osteoporosis
Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Prevalence of Osteoporosis in Hemodialysis Patients and Relevance With Renal Bone Disease

Resource links provided by NLM:


Further study details as provided by Papageorgiou General Hospital:

Enrollment: 166
Study Start Date: January 2005
Study Completion Date: August 2007
Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients on hemodialysis

Criteria

Inclusion Criteria:

  • Chronic hemodialysis
  • Age > 18-year old

Exclusion Criteria:

  • Prior specific osteoporosis treatment except vitamin D and calcium supplement administration; active malignancy
  • Recent pregnancy
  • Immobilization
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00308828

Locations
Greece
Papageorgiou General Hospital
Thessaloniki, Greece, 56429
Sponsors and Collaborators
Papageorgiou General Hospital
Investigators
Principal Investigator: Efstathios Mitsopoulos, MD Papageorgiou General Hospital
  More Information

No publications provided

Responsible Party: Efstathios Mitsopoulos, Papageorgiou General Hospital, Thessaloniki, Greece
ClinicalTrials.gov Identifier: NCT00308828     History of Changes
Other Study ID Numbers: 47/31-1-2005
Study First Received: March 29, 2006
Last Updated: June 5, 2008
Health Authority: Greece: Ministry of Health and Welfare

Additional relevant MeSH terms:
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on July 26, 2014